Related Experiment Video
Updated: Aug 29, 2026

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
[Consumption of "performance-enhancing" products by general practitioners]
Patrick Laure1, Caroline Binsinger
1Laboratoire de Psychologie Appliquée Stress et Société, Université de Reims, Reims, France. patrick.laure@wanadoo.fr
Abstract:
The aim of this work was to test the hypothesis that doctors consume products to help them in their professional practice. A telephone survey was conducted over a 12-month period among 402 general practitioners in France (using a 'quota method'). The 202 respondents consisted of 49 women and 153 men, with a mean age of 45.6 +/- 5.6 years. Nineteen percent of these respondents said that they had taken products to help with stress (11% had used benzodiazepines), 24% had used products to help with fatigue, 33% had used tobacco, and 20% said that they had experimented with cannabis. Finally, 44% of the respondents said that they had used products to 'hold out' during their studies--especially those presently taking products to assist with stress. Two questions must therefore be raised: (i) what is the impact of this addiction on the types of products prescribed by these doctors? and (ii) what steps are taken to prevent doctors from using such products and becoming addicted in the first place?
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The Placebo Effect
Drug Abuse and Addiction: Pharmacological Phenomena
Factors Affecting Drug Response: Overview
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
